✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Onesource Specialty Pharma Ltd.

ONESOURCE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹21,029 Cr.
P/E
0.00

Onesource Specialty Pharma Ltd.

  • Onesource Specialty
  • Neuland Laboratories
  • Astrazeneca Pharma I
FAQs on Onesource Specialty Pharma Ltd. Shareprice

There is not enough historical data for the companies share price.

Onesource Specialty is not expensive.
Latest PE of Onesource Specialty is 0.0, while 3 year average PE is 2.47.
Also latest EV/EBITDA of Onesource Specialty is 51.89 while 3yr average is 110.

View FAQ's On Business
Growth Table
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Balance Sheet
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Cash Flow
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Quarterly Results
  • Onesource Specialty Pharma Ltd.
  • Neuland Laboratories
  • Astrazeneca Pharma I
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Onesource Specialty Pharma Ltd. Financials

Balance sheet of Onesource Specialty is strong.
But short term working capital might become an issue for this company.

The net debt of Onesource Specialty is decreasing.
Latest net debt of Onesource Specialty is ₹170 Crs as of Mar-25.
This is less than Mar-24 when it was ₹442 Crs.

Yes, profit is increasing.
The profit of Onesource Specialty is -₹9.61 Crs for TTM, -₹17.97 Crs for Mar 2025 and -₹391.17 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onesource Specialty latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech